Sunday, 8 November 2026
M
Meridian Globe
Live briefing
New Zealand election campaign dominated by cost of living, healthcare— 日经 Nikkei AsiaIn Focus: Salmon disappearing as Japan's catch just 3% of 2003 peak— 日经 Nikkei AsiaUS war in Iran leaves Sri Lanka in troubled diplomatic waters— 日经 Nikkei AsiaAsia's AI supply chain and US data centers set to weather 'blue wave'— 日经 Nikkei AsiaJapan demands Russia reverse seizure of Japan Tobacco units— 日经 Nikkei AsiaIndia's IT lobby chief warns grads could struggle to find jobs due to AI— 日经 Nikkei AsiaActivist Au Kam-san jailed 12.5 years in 1st Macao national security case— 日经 Nikkei AsiaTaiwan's KMT old guard fights for power base in tight Taipei mayoral races— 日经 Nikkei AsiaNew Zealand election campaign dominated by cost of living, healthcare— 日经 Nikkei AsiaIn Focus: Salmon disappearing as Japan's catch just 3% of 2003 peak— 日经 Nikkei AsiaUS war in Iran leaves Sri Lanka in troubled diplomatic waters— 日经 Nikkei AsiaAsia's AI supply chain and US data centers set to weather 'blue wave'— 日经 Nikkei AsiaJapan demands Russia reverse seizure of Japan Tobacco units— 日经 Nikkei AsiaIndia's IT lobby chief warns grads could struggle to find jobs due to AI— 日经 Nikkei AsiaActivist Au Kam-san jailed 12.5 years in 1st Macao national security case— 日经 Nikkei AsiaTaiwan's KMT old guard fights for power base in tight Taipei mayoral races— 日经 Nikkei Asia

First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation

Source Nature 生命科学16h ago
Summary

We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.

Open original
Desk
Science
Region
Global
Language
English
Item ID
science-13e6f634

Comments 0 comments

No comments yet. Be the first.

First-line CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer with chronic kidney disease stage 3b–5: a target trial emulation · Meridian Globe